HIMS
Hims & Hers Health, Inc. NYSE Listed Sep 13, 2019$35.47
+11.23%
vs $31.89
Mkt Cap $9.2B
52w Low $14.52
40.6% of range
52w High $66.18
50d MA $26.64
200d MA $33.36
P/E (TTM)
—
EV/EBITDA
322.6x
P/B
14.8x
Debt/Equity
2.3x
ROE
23.7%
P/FCF
123.8x
RSI (14)
73.30
ATR (14)
$2.36
Beta
2.31
50d MA
$26.64
200d MA
$33.36
Avg Volume
22.8M
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
2269 Chestnut Street · San Francisco, CA 94123 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | AMC | 0.02 | 0.07 | +250.0% | 15.51 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% | — |
| Nov 3, 2025 | AMC | 0.09 | 0.06 | -33.3% | 44.39 | +3.1% | -3.6% | +2.2% | -5.1% | -1.2% | +0.0% | — |
| Aug 4, 2025 | AMC | 0.18 | 0.17 | -5.6% | 63.35 | -12.7% | -12.4% | -7.9% | -0.2% | +1.7% | -3.8% | — |
| May 5, 2025 | AMC | 0.12 | 0.20 | +65.4% | 41.88 | -8.5% | +18.1% | +5.8% | -1.8% | +1.1% | +6.3% | — |
| Feb 24, 2025 | AMC | 0.09 | 0.11 | +22.2% | 51.31 | -22.3% | -22.3% | +5.1% | -1.3% | +9.1% | -9.8% | — |
| Nov 4, 2024 | AMC | 0.06 | 0.06 | +0.0% | 20.76 | +6.4% | -0.6% | +13.5% | +0.9% | -0.9% | +19.1% | — |
| Aug 5, 2024 | AMC | 0.04 | 0.06 | +40.5% | 17.84 | -1.8% | -5.4% | -5.0% | -1.2% | +0.7% | +0.1% | — |
| May 6, 2024 | AMC | 0.01 | 0.05 | +316.7% | 11.65 | +17.1% | +6.0% | -1.6% | +6.3% | -4.9% | +4.9% | — |
| Feb 26, 2024 | AMC | 0.00 | 0.01 | +151.9% | 10.25 | +20.3% | +31.0% | -0.7% | -2.2% | +0.6% | +12.0% | — |
| Nov 6, 2023 | AMC | -0.03 | -0.04 | -27.4% | 6.28 | +7.8% | +11.0% | +0.7% | -5.6% | +2.7% | +2.8% | — |
| Aug 7, 2023 | AMC | -0.05 | -0.03 | +40.0% | 7.90 | +17.2% | -5.8% | -1.6% | -1.8% | +0.1% | -1.1% | — |
| May 8, 2023 | AMC | -0.07 | -0.05 | +28.6% | 11.85 | -9.1% | -10.1% | +0.5% | -1.2% | +2.3% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 | Needham | Reiterates | Buy | $35 | $29.14 | $25.21 | -13.5% | -14.1% | -3.6% | +0.4% | +3.3% | -11.0% |
| Apr 24 | JP Morgan | Initiates | Overweight | $35 | $28.15 | $29.50 | +4.8% | +8.6% | -3.8% | -5.0% | -5.7% | +3.2% |
| Apr 24 | BofA Securities | Maintains | Neutral → Neutral | — | $28.15 | $29.50 | +4.8% | +8.6% | -3.8% | -5.0% | -5.7% | +3.2% |
| Apr 16 | BofA Securities | Maintains | Neutral → Neutral | — | $24.29 | $26.15 | +7.7% | +11.1% | +6.8% | +7.6% | -4.0% | -2.5% |
| Mar 27 | TD Cowen | Maintains | Hold → Hold | — | $20.86 | $20.58 | -1.3% | -7.1% | -3.1% | +10.5% | -4.4% | -3.5% |
| Mar 16 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $24.77 | $24.22 | -2.2% | +0.4% | +0.4% | -7.3% | +4.4% | -8.9% |
| Mar 11 | Barclays | Maintains | Overweight → Overweight | — | $23.47 | $23.12 | -1.5% | +10.3% | -7.9% | +3.9% | +0.4% | +0.4% |
| Mar 10 | Deutsche Bank | Maintains | Hold → Hold | — | $22.16 | $24.00 | +8.3% | +5.9% | +10.3% | -7.9% | +3.9% | +0.4% |
| Mar 10 | Citigroup | Upgrade | Sell → Neutral | — | $22.16 | $24.00 | +8.3% | +5.9% | +10.3% | -7.9% | +3.9% | +0.4% |
| Mar 10 | BofA Securities | Upgrade | Underperform → Neutral | — | $22.16 | $24.00 | +8.3% | +5.9% | +10.3% | -7.9% | +3.9% | +0.4% |
| Mar 9 | Needham | Upgrade | Hold → Buy | — | $15.74 | $23.22 | +47.5% | +40.8% | +5.9% | +10.3% | -7.9% | +3.9% |
| Feb 25 | Barclays | Maintains | Overweight → Overweight | — | $15.46 | $15.67 | +1.4% | +2.3% | -1.4% | -6.9% | +13.5% | -4.0% |
| Feb 25 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.46 | $15.67 | +1.4% | +2.3% | -1.4% | -6.9% | +13.5% | -4.0% |
| Feb 24 | Truist | Maintains | Hold → Hold | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% |
| Feb 24 | TD Cowen | Maintains | Hold → Hold | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% |
| Feb 24 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% |
| Feb 24 | Evercore ISI | Maintains | In Line → In Line | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% |
| Feb 24 | Citigroup | Maintains | Sell → Sell | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% |
| Feb 24 | BTIG | Downgrade | Buy → Neutral | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.3% | -1.4% | -6.9% | +13.5% |
| Feb 9 | TD Cowen | Maintains | Hold → Hold | — | $23.02 | $17.83 | -22.5% | -16.0% | -10.8% | -3.2% | -5.3% | +3.2% |
| Feb 9 | BofA Securities | Maintains | Underperform → Underperform | — | $23.02 | $17.83 | -22.5% | -16.0% | -10.8% | -3.2% | -5.3% | +3.2% |
| Feb 9 | Citigroup | Maintains | Sell → Sell | — | $23.02 | $17.83 | -22.5% | -16.0% | -10.8% | -3.2% | -5.3% | +3.2% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $27.09 | $27.11 | +0.1% | -2.4% | -3.4% | -4.5% | -3.8% | -2.0% |
| Nov 4 | BofA Securities | Maintains | Underperform → Underperform | — | $44.39 | $45.75 | +3.1% | -3.6% | +2.2% | -5.1% | -1.2% | +0.0% |
| Nov 4 | BTIG | Maintains | Buy → Buy | — | $44.39 | $45.75 | +3.1% | -3.6% | +2.2% | -5.1% | -1.2% | +0.0% |
| Sep 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $51.76 | $51.03 | -1.4% | +7.2% | -2.8% | -5.7% | -1.1% | +11.6% |
| Aug 18 | Truist | Maintains | Hold → Hold | — | $46.02 | $45.22 | -1.7% | -2.0% | -6.5% | +2.8% | +1.3% | +1.4% |
| Aug 5 | Needham | Maintains | Hold → Hold | — | $63.35 | $55.30 | -12.7% | -12.4% | -7.9% | -0.2% | +1.7% | -3.8% |
| Jul 17 | Truist | Maintains | Hold → Hold | — | $51.85 | $51.72 | -0.3% | -3.6% | +0.8% | -5.5% | +5.1% | +16.0% |
| Jun 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $55.25 | $54.68 | -1.0% | +4.2% | -0.7% | -2.9% | +7.8% | -0.9% |
| Jun 4 | Needham | Maintains | Buy → Buy | — | $54.73 | $55.77 | +1.9% | -2.0% | -1.6% | +6.7% | +0.9% | -2.8% |
| May 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $41.88 | $38.33 | -8.5% | +18.1% | +5.8% | -1.8% | +1.1% | +6.3% |
| May 6 | Needham | Maintains | Buy → Buy | — | $41.88 | $38.33 | -8.5% | +18.1% | +5.8% | -1.8% | +1.1% | +6.3% |
| May 6 | Citigroup | Maintains | Sell → Sell | — | $41.88 | $38.33 | -8.5% | +18.1% | +5.8% | -1.8% | +1.1% | +6.3% |
| Apr 29 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $28.48 | $37.94 | +33.2% | +23.0% | -5.5% | +9.2% | +12.9% | +2.6% |
| Apr 29 | TD Cowen | Downgrade | Buy → Hold | — | $28.48 | $37.94 | +33.2% | +23.0% | -5.5% | +9.2% | +12.9% | +2.6% |
| Apr 29 | BofA Securities | Maintains | Underperform → Underperform | — | $28.48 | $37.94 | +33.2% | +23.0% | -5.5% | +9.2% | +12.9% | +2.6% |
| Apr 25 | Citigroup | Maintains | Sell → Sell | — | $28.14 | $27.86 | -1.0% | -0.2% | +1.4% | +23.0% | -5.5% | +9.2% |
| Apr 10 | Truist | Maintains | Hold → Hold | — | $29.49 | $28.49 | -3.4% | -9.1% | +1.6% | +4.0% | +4.1% | -8.5% |
| Mar 18 | BofA Securities | Maintains | Underperform → Underperform | — | $34.69 | $34.31 | -1.1% | -9.2% | +7.6% | -3.0% | +5.7% | +7.7% |
| Mar 6 | Citigroup | Maintains | Sell → Sell | — | $40.89 | $37.40 | -8.5% | -15.9% | +4.5% | -4.1% | +0.7% | -2.2% |
| Mar 6 | BofA Securities | Maintains | Underperform → Underperform | — | $40.89 | $37.40 | -8.5% | -15.9% | +4.5% | -4.1% | +0.7% | -2.2% |
| Feb 26 | Truist | Maintains | Hold → Hold | — | $39.86 | $40.24 | +1.0% | +5.1% | -1.3% | +9.1% | -9.8% | -0.5% |
| Feb 25 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $51.31 | $39.88 | -22.3% | -22.3% | +5.1% | -1.3% | +9.1% | -9.8% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $51.31 | $39.88 | -22.3% | -22.3% | +5.1% | -1.3% | +9.1% | -9.8% |
| Feb 25 | Citigroup | Maintains | Sell → Sell | — | $51.31 | $39.88 | -22.3% | -22.3% | +5.1% | -1.3% | +9.1% | -9.8% |
| Feb 25 | Piper Sandler | Maintains | Neutral → Neutral | — | $51.31 | $39.88 | -22.3% | -22.3% | +5.1% | -1.3% | +9.1% | -9.8% |
| Feb 20 | BofA Securities | Maintains | Underperform → Underperform | — | $68.74 | $65.08 | -5.3% | -3.4% | -25.8% | +4.1% | -22.3% | +5.1% |
| Feb 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.50 | $59.26 | +1.3% | +17.5% | -3.4% | -25.8% | +4.1% | -22.3% |
| Feb 18 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $60.47 | $60.70 | +0.4% | -3.3% | +17.5% | -3.4% | -25.8% | +4.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Elshenawy MohamedOff | CTO | Sell | 30,040 | $31.50 | $946K | 101,023 | +11.23% | — |
| Jun 17, 2026 | Becklund IreneOff | PAO | Sell | 4,490 | $31.50 | $141K | 6,790 | +11.23% | — |
| Jun 17, 2026 | Chi MichaelOff | Chief Operating Officer | Sell | 14,027 | $31.50 | $442K | 432,124 | +11.23% | — |
| Jun 16, 2026 | Becklund IreneOff | PAO | Sell | 7,573 | $30.25 | $229K | 11,280 | +11.23% | — |
| May 26, 2026 | WELLS DAVID BDir | — | Buy | 48,400 | $24.23 | $1.2M | 224,417 | +5.66% | -0.90% |
| May 18, 2026 | Okupe OluyemiOff | Chief Financial Officer | Sell | 7,950 | $23.64 | $188K | 262,954 | +2.67% | +5.66% |
8-K
Hims & Hers Health, Inc. -- 8-K Filing
I cannot provide a meaningful analysis based on this filing summary, as it contains only technical metadata and XBRL references without substantive business information about Hims & Hers.
Jun 15
8-K · 8.01
!! High
Hims & Hers Health, Inc. -- 8-K 8.01: Material Event / Announcement
Hims & Hers Health issued a press release announcement regarding a material event, though the specific details require reviewing the attached exhibit for investor impact assessment.
Jun 2
8-K · 8.01
!! High
Hims & Hers Health, Inc. -- 8-K 8.01: Material Event / Announcement
May 19
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Hims secured a strategic Novo Nordisk partnership to expand GLP-1 weight-loss offerings, positioning it competitively in the booming telehealth obesity market and diversifying beyond single-drug dependency.
Mar 11
8-K
Hims & Hers Health, Inc. -- 8-K Filing
Hims & Hers reported fourth quarter and full year 2025 financial results, with CFO Oluyemi Okupe as principal financial officer; detailed results available in shareholder letter.
Feb 23
8-K · 1.01
!! High
Hims & Hers Health, Inc. -- 8-K 1.01: Material Agreement
Hims & Hers is expanding internationally through a strategic acquisition of an Australia-based digital health operator with established presence in five countries, strengthening its global telehealth footprint.
Feb 19
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 7,858,464 | $255M | Reduced | Dec 2025 |
| 2 | Vanguard Portfolio Management Llc | 10,183,813 | $211M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 9,339,711 | $194M | New | Mar 2026 |
| 4 | Jpmorgan Chase & Co | 5,240,816 | $98M | Reduced | Mar 2026 |
| 5 | Bank Of America Corp /de/ | 4,357,672 | $90M | Added | Mar 2026 |
| 6 | Ubs Group Ag | 4,151,638 | $86M | Reduced | Mar 2026 |
| 7 | Northern Trust Corp | 2,436,029 | $51M | Added | Mar 2026 |
| 8 | State Of Michigan Retirement System | 2,338,600 | $49M | Added | Mar 2026 |
| 9 | Jane Street Group, Llc | 1,476,960 | $48M | Reduced | Dec 2025 |
| 10 | Cantor Fitzgerald, L. P. | 1,451,446 | $47M | New | Dec 2025 |
| 11 | Renaissance Technologies Llc | 2,118,080 | $44M | Reduced | Mar 2026 |
| 12 | Susquehanna International Group, Llp | 1,634,741 | $34M | — | Mar 2026 |
| 13 | Bank Of New York Mellon Corp | 1,340,446 | $28M | Reduced | Mar 2026 |
| 14 | Marex Group Plc | 1,338,814 | $28M | Reduced | Mar 2026 |
| 15 | Bank Of Montreal /can/ | 1,098,996 | $23M | Reduced | Mar 2026 |
| 16 | Principal Financial Group Inc | 649,984 | $21M | Reduced | Dec 2025 |
| 17 | Marshall Wace, Llp | 724,227 | $15M | Added | Mar 2026 |
| 18 | Citadel Advisors Llc | 694,774 | $14M | Reduced | Mar 2026 |
| 19 | Nuveen, Llc | 678,120 | $14M | Added | Mar 2026 |
| 20 | Bnp Paribas Financial Markets | 664,167 | $14M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$9.16B
Enterprise Value
$9.70B
P/E (TTM)
—
Forward P/E
71.18x
PEG Ratio
-33.00x
P/B
14.75x
P/S
3.87x
P/FCF
123.84x
EV/EBITDA
322.64x
Shares Out
258.2M
Financials (TTM)
Revenue
$2.37B
Net Income
-$13.2M
EBITDA
$30.1M
Free Cash Flow
$74.0M
Op Cash Flow
$300.0M
EPS Basic
$0.57
EPS Diluted
$-0.09
EPS Forward
$0.50
Gross Margin
67.6%
Op Margin
1.3%
Net Margin
-0.6%
Balance Sheet
Total Assets
$2.15B
Total Liab.
$1.61B
Total Equity
$540.9M
Cash
$577.5M
LT Debt
$1.12B
Book Value/Sh
$2.40
Debt/Equity
2.34x
Current Ratio
1.90
Quick Ratio
1.61
Returns & Growth
ROE
23.7%
ROA
6.0%
ROIC
6.0%
Rev Growth YoY
+59.0%
EPS Growth YoY
-1.7%
Price Returns
2W
+7.9%
1M
-3.8%
3M
+80.1%
6M
-34.2%
12M
-53.8%
Technicals
52W High
$66.18
52W Low
$14.52
50d MA
$26.64
200d MA
$33.36
RSI (14)
73.30
ATR (14)
$2.36
Beta
2.31
Avg Volume
22.8M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$29.67
High
$60.00
Low
$12.50
Median
$26.50
Data updated apr 25, 2026 1:28pm
· Source: financialmodelingprep.com